Jiangsu Chia Tai Feng Hai Pharmaceutical Co., Ltd.
江蘇正大豐海製藥有限公司
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-01-29 | Formation Bio (asset housed in Kenmare Bio) | FHND5032 | Not disclosed | Not disclosed | ≤ USD 500,000,000 | IND stage |